WallStreetZenWallStreetZen

NASDAQ: ARTV
Artiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Artiva Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Heather RaymonSVP Research and Development2026-02-151,521$4.00
$6.08kSell
Fred AslanPresident and CEO2026-02-1514,600$4.00
$58.40kSell
Jennifer BushCOO CLO Secy Compliance Off2026-02-153,515$4.00
$14.06kSell
Christopher HoranChief Tech Operations Officer2026-02-152,187$4.00
$8.75kSell
Fred AslanPresident and CEO2025-12-153,187$6.00
$19.12kSell
Fred AslanPresident and CEO2025-11-176,375$3.38
$21.52kSell
Neha KrishnamohanChief Financial Officer2025-11-153,490$3.25
$11.34kSell
Christopher HoranChief Tech Operations Officer2025-11-151,899$3.25
$6.17kSell
Jennifer BushCOO CLO Secy Compliance Off2025-11-153,055$3.25
$9.93kSell
Fred AslanPresident and CEO2025-11-156,347$3.25
$20.63kSell

1 of 3

ARTV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARTV insiders and whales buy or sell their stock.

ARTV Shareholders

What type of owners hold Artiva Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP39.87%9,853,302$60.89MInstitution
Yongjun Huh19.89%4,916,249$30.38MInsider
Gc Corp18.48%4,567,412$28.23MInsider
5am Partners VI LLC9.52%2,353,304$14.54MInsider
5am Venture Management LLC9.52%2,353,304$14.54MInstitution
Venbio Global Strategic Fund III LP7.84%1,936,637$11.97MInsider
Vr Adviser LLC6.51%1,609,569$9.95MInstitution
Fred Aslan6.32%1,562,198$9.65MInsider
Ra Capital Management LP3.35%826,832$5.11MInsider
Venbio Partners LLC2.62%648,507$4.01MInstitution

1 of 3

ARTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTV48.92%51.08%Net SellingNet Selling
IMUX39.30%12.50%Net Buying
EQ57.95%23.48%Net SellingNet Selling
CNTB15.14%0.00%
IKT83.08%16.92%Net Buying
View Top Biotech Stocks

Artiva Biotherapeutics Stock Ownership FAQ

Who owns Artiva Biotherapeutics?

Artiva Biotherapeutics (NASDAQ: ARTV) is owned by 68.60% institutional shareholders, 71.64% Artiva Biotherapeutics insiders, and 0.00% retail investors. Yongjun Huh is the largest individual Artiva Biotherapeutics shareholder, owning 4.92M shares representing 19.89% of the company. Yongjun Huh's Artiva Biotherapeutics shares are currently valued at $30.38M.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.